According to iBio's latest financial reports and stock price the company's current number of shares outstanding is 1,856,000. At the end of 2023 the company had 1,856,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 1.85 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 129,598.28% | ๐บ๐ธ USA |
Genocea Biosciences
GNCA | 71,120,000 | 3,731.90% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | 190,406,000 | 10,158.94% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 51,800,000 | 2,690.95% | ๐บ๐ธ USA |